ENTITY
Sino Biopharmaceutical

Sino Biopharmaceutical (1177 HK)

284
Analysis
Health Care • Hong Kong
Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.
more
bullish•Burning Rock Biotech
•24 May 2020 16:54

Burning Rock Biotech IPO Initiation: Burning Ambitions

Burning Rock Biotech (BNR US) is a precision oncology and early cancer detection company. It is China’s number one NGS-based cancer therapy...

Logo
371 Views
Share
bullish•Quantitative Analysis
•13 May 2020 07:56

China Health Care - Allocation Boom: Wuxi Biologics/Jinyu Bio-Tech/Hangzhou Tigermed Top Picks

With increased focus on the Health Care sector in light of the COVID-19 pandemic, Health Care allocations reached record levels last month. We...

Logo
431 Views
Share
bullish•Quantitative Analysis
•03 May 2020 16:56

HK Connect Weekly: Tencent, Ping An Good Dr, Sino Biopharm, SMIC, CSPC, Sunny Optical

In our weekly HK Connect Flow series, we aim to highlight key stocks and sectors which the mainland investors traded via the southbound  Hong Kong...

Logo
344 Views
Share
bullish•Quantitative Analysis
•27 Apr 2020 15:59

HK Connect Weekly: Tencent, Sino Biopharm, CSPC, SMIC

In our weekly HK Connect Flow series, we aim to highlight key stocks and sectors which the mainland investors traded via the southbound  Hong Kong...

Logo
358 Views
Share
x